Stockreport

MAIA Biotechnology Announces New Updates from Phase 2 Trial of Novel Cancer Treatment Agent [Yahoo! Finance]

MAIA Biotechnology, Inc.  (MAIA) 
PDF 6 patients on trial regimen for more than 12 months have completed up to 21 cycles, with treatment ongoing CHICAGO, July 23, 2024 BUSINESS WIRE MAIA Biotechnology, In [Read more]